Duplicate_Institut klinicke a experimentalni mediciny (IKEM) /ID# 165465
Prague, Praha 4 140 00
0 studies enrolling now ยท 1 studies all time
What they study most
Crohn's Disease
Studies at this site
- A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease โ Running, not enrolling